Compositions and methods for diagnosis and treatment of inflammation
View Patent ↗Compositions including an fatty acid, such as an odd chain fatty acid or a very long even chain fatty acid, and salts and derivatives thereof, and methods for treatment and prophylaxis of conditions related to inflammation and conditions related to inflammation, including anemia of chronic disease, insulin resistance, metabolic syndrome, autoimmune disease, hypertension, diabetes, nonalcoholic fatty liver disease, cardiovascular disease, cancer, aging, neurodegenerative diseases, including Alzheimer's disease and other forms of dementia, and other related conditions, and other related conditions.
1. A method of treatment of inflammation, comprising:
administering to a patient in need thereof a composition comprising an effective amount of at least one odd-chain saturated fatty acid, or pharmaceutically acceptable salts thereof, wherein the at least one odd-chain saturated fatty acid is selected from the group consisting of C15:0, C17:0, and combinations thereof.
2. The method of claim 1 , wherein the at least one odd-chain saturated fatty acid or pharmaceutically acceptable salts thereof is provided as a pharmaceutical composition in a unit dosage form comprising the at least one odd-chain saturated fatty acid or pharmaceutically acceptable salts thereof and a pharmaceutically acceptable carrier.
3. The method of any one of claims 1 through 2 , wherein the unit dosage form comprises from 0.01 mg to 10000 mg of the at least one odd-chain saturated fatty acid or pharmaceutically acceptable salts thereof.
4. The method of any one of claims 1 through 3 , wherein the at least one odd chain saturated fatty acids is heptadecanoic acid or pentadecanoic acid.
5. The method of any one of claims 1 through 4 , wherein the pharmaceutical composition is substantially free from even chain saturated fatty acids.
6. The method of any one of claims 1 through 5 , wherein the pharmaceutical composition comprises a plurality of different odd-chain saturated fatty acids.
7. The method of any one of claims 1 through 5 or 6 , wherein from 2.5 mg to 11 mg of the at least one odd-chain saturated fatty acid or pharmaceutically acceptable salts thereof is administered to the patient, per 1 kg of body weight, per day.
8. The method of any one of claims 1 through 5 or 6 - 7 , wherein the at least one odd-chain saturated fatty acid or pharmaceutically acceptable salts thereof is administered to the patient once per day.
9. The method of any one of claims 1 through 5 or 6 - 8 , wherein a serum concentration or a red blood cell membrane concentration of the at least one odd-chain saturated fatty acid is increased by at least about 0.001×10 −4 M above a pretreatment value.
10. The method of treatment of claim 1 , wherein the composition further comprises an effective amount of at least one even-chain saturated fatty acid, wherein the at least one even-chain saturated fatty acid is selected from the group consisting of C16:0, C18:0, and combinations thereof.
11. The method of treatment of claim 1 , wherein the composition further comprises an effective amount of at least one very long even chain saturated fatty acid, wherein the at least one very long even chain saturated fatty acid is selected from the group consisting of C20:0, C:22:0, and C24:0, and combinations thereof.
12. The method of treatment of claim 10 , wherein the composition further comprises an effective amount of at least one very long even chain saturated fatty acid, wherein the at least one very long even chain saturated fatty acid is selected from the group consisting of C20:0, C:22:0, and C24:0, and combinations thereof.